General Information of This Metabolic Reaction (MR) (ID: MR007257)
Formula
SVG example
Reactant ANW-60941 Product ANW-60941 M10
Reactant Info Product Info
Other MR(s) Related to The Reactant of This MR
Other MR(s) That Metabolize The Reactant of This MR
MR ID Reactant Product MR Type Related Drug REF
MR007259 ANW-60941 ANW-60941 M26 Conjugation - Glucuronidation ANW-60941 [1]
MR007254 ANW-60941 ANW-60941 M6 Unclear ANW-60941 [1]
MR007260 ANW-60941 ANW-60941 M8 Conjugation - Methylationn ANW-60941 [1]
MR007261 ANW-60941 ANW-60941 M9 Oxidation - Oxidationn ANW-60941 [1]
Other MR(s) Related to The Product of This MR
Other MR(s) That Metabolize The Produtc of This MR
MR ID Reactant Product MR Type Related Drug REF
MR007258 ANW-60941 M10 ANW-60941 M2 Conjugation - Sulfation ANW-60941 [1]
References
1 Disposition and metabolism of 14C-dovitinib (TKI258), an inhibitor of FGFR and VEGFR, after oral administration in patients with advanced solid tumors

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.